PENERAPAN TANADASHIP PADA KECEMASAN PASIEN KOMORBID DENGAN COVID-19
Keywords:
anxiety, comorbid, Covid-19, TANADASHIPAbstract
Covid-19 or corona virus disease is a new strain of coronaviruses. This disease firstly reported in the city of Wuhan, China, In December 2019. The spread of the virus swiftly became a global health threat. It is believed that patient with chronic diseases such as diabetes, cardiovascular diseases, auto-immune disease, kidney failure, hypertension, chronic obstructive pulmonary disease, and cancer, are susceptible to respiratory failure and may have poorer outcome. Covid-19 patient who present with a comorbid condition may experiencing physically and psychological changes. In addition, negative information and stigma in society can cause psychosocial problems, such as anxiety. Aim: This study aims to overcome anxiety by using TANADASHIP. TANADASHIP is a collection of actions include deep breathing, spiritual and five finger hypnosis. Method: In experimental study, using pre-post design, a total of 28 Covid-19 patients with comorbid were included. Before and after intervention, anxiety scale was used to measure and record patient anxiety. Data analysis was performed using SPSS 25.0 Software. Results: The average anxiety score before intervention was not statistically significant (p = 0.052). Discussion:based on the calculation of the data, it was found that there was a decrease in the level of anxiety in the respondents, which previously obtained 14 respondents experiencing anxiety after the intervention using video, it was found that only 6 respondents still experienced anxiety with a mild level of anxiety. Conclusion:Based on the results of the study, the use of the TANADASHIP method is very suitable for reducing anxiety levels. Researchers assess very effective in any situation and condition
Downloads
Published
How to Cite
Issue
Section
Copyright (c) 2023 Slametiningsih Slametiningsih, Neneng Kurwiyah, Nuraenah Nuraenah, Rhadiatan Khalila, Putri Larasati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.